Peter MD vs Yucca Health: Compare GLP-1 Programs & Pricing
Side-by-side Peter MD and Yucca Health: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Peter MD and Yucca Health are telehealth providers that offer GLP-1–based weight management options under clinician supervision. This comparison focuses on onboarding, pricing transparency, medical oversight, medication quality, and patient experience so you can decide which telehealth program aligns with your needs. It does not replace clinical advice; prescription GLP-1 medications require clinician evaluation and are provided only when appropriate.
Visit Peter MD
Explore Yucca Health
Peter MD vs Yucca Health: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Peter MD | — | — | ||
| Yucca Health | $146.00 | $279.00 | — | — |
The table reflects publicly available starting prices when listed. If a provider does not show pricing or offers personalized quotes, the relevant cells remain blank above. Always confirm current fees on the provider site before enrolling; telehealth pricing and offers can change.
Peter MD vs Yucca Health: Medical Process & Accessibility
Peter MD typically emphasizes rapid telehealth intake and clinician review to determine eligibility for GLP-1 therapy. Yucca Health uses an initial virtual consultation followed by structured follow-ups for dose titration and symptom assessment. Both operate within U.S. telemedicine rules and connect patients with licensed clinicians; prescriptions are issued only after a medical evaluation and appropriate screening.
Peter MD vs Yucca Health: Pricing Comparison
Pricing transparency varies between the two. Yucca Health lists starting prices of $146.00 for semaglutide and $279.00 for tirzepatide. Peter MD does not list a public starting price in the supplied data, so prospective patients may need to request a quote during intake. When comparing, include consultation fees, medication price, shipping, and any membership costs to estimate total monthly expense.
Because prices can depend on compound strength, formulation, and quantity, they may differ from branded FDA-approved products like Wegovy® or Mounjaro®. Compounded alternatives are sometimes offered by telehealth-affiliated pharmacies but are not equivalent to branded products; clinicians should discuss risks, benefits, and FDA status during consultation.
Peter MD vs Yucca Health: Clinical Oversight & Support
Both providers connect patients with licensed medical professionals who assess medical history, contraindications, and potential drug interactions. Follow-up care is important with GLP-1 therapies; Yucca emphasizes structured follow-ups and dose optimization, while Peter MD may prioritize faster onboarding. Ensure any provider offers clear instructions for side-effect management and emergency contacts.
Book a Consultation with Peter MD
Peter MD vs Yucca Health: Medication Quality & Safety
Medications dispensed through these telehealth services typically come from licensed U.S. pharmacies. Branded GLP-1 drugs have FDA-approved labeling; compounded formulations are legal when prescribed but are not FDA-branded products. Telehealth providers should follow safe prescribing practices, screening for contraindications (like pregnancy or certain GI disorders) and advising on common side effects such as nausea, dizziness, or hypoglycemia risk if applicable.
Check Yucca Health Safety Info
Peter MD vs Yucca Health: Customer Experience
User reports indicate Peter MD may be favored for straightforward onboarding and cost focus, while Yucca Health is noted for attentive follow-up and clinical touchpoints. Shipping times, patient portal usability, and clinician response vary; read recent reviews and ask about refill processes and lab monitoring before enrolling.
Peter MD vs Yucca Health: Final Verdict
Choose Peter MD if you want speed and an entry path that may emphasize affordability and quick access. Choose Yucca Health if you prioritize transparent starting prices and structured follow-up for dose adjustments. Both are legitimate telehealth pathways to prescription GLP-1 therapies, but neither should be used without clinician supervision and a personalized risk/benefit discussion.
Join Peter MD
Get Started with Yucca Health
Disclaimer
This article is informational and not medical advice. GLP-1 therapies require a prescription and clinical oversight. Pricing and program details may change; check provider sites for current information. Always consult a licensed clinician before beginning any medication. ExploreProviders.com may earn affiliate fees from links at no extra cost to you.